NGS Panel Portfolio Bene T from Our Medical Expertise and Streamlined Genetic Testing
NGS Panel Portfolio Bene t from our Medical Expertise and Streamlined Genetic Testing CENTOGENE has recently added the following Next Generation Sequencing panels and gene updates to its portfolio (10 Jan. 2020). CENTOGENE‘s NGS panel composition always re ects the clinical relevance to the speci c disease phenotype. All of our NGS panels are processed with a standardized quality scheme and internal controls. Amyotrophic lateral sclerosis panel ALS2, ANG, C9orf72, CHCHD10, CHMP2B, CSF1R, DCTN1, ERBB4, FIG4, FUS, GRN, HNRNPA1, ITM2B, KIF5A, MAPT, MATR3, NEFH, OPTN, PFN1, PRNP, PRPH, PSEN1, PSEN2, SETX, SIGMAR1, SLC52A3, SOD1, SPG11, SQSTM1, TARDBP, TBK1, TREM2, TUBA4A, UBQLN2, VAPB, VCP Abnormal mineralization panel ABCC6, ALPL, ANKH, ANO5, AP2S1, BMP1, CA2, CASR, CLCN5, CLCN7, COL1A1, COL1A2, CREB3L1, CRTAP, CYP27B1, CYP2R1, DMP1, ENPP1, FAH, FGF23, FGFR1, FGFR3, FKBP10, GALNT3, GJA1, GNA11, GNAS, GORAB, HPGD, HRAS, IFITM5, KRAS, LRP5, MBTPS2, MTAP, NOTCH2, NRAS, OCRL, OSTM1, P3H1, P4HB, PHEX, PLEKHM1, PLOD2, PLS3, PPIB, PTDSS1, PTH1R, SERPINF1, SERPINH1, SLC26A2, SLC34A1, SLC34A3, SLC9A3R1, SLCO2A1, SNX10, SOST, SOX9, SP7, TBXAS1, TCIRG1, TGFB1, TMEM38B, TNFRSF11A, TNFRSF11B, TNFSF11, TYROBP, VDR, WNT1 Ataxia panel ABCB7, ABHD12, ABHD5, ACADVL, ACO2, AFG3L2, AHI1, ALDH5A1, AMACR, ANO10, AP1S2, APTX, ARL13B, ARL6, ARSA, ATCAY, ATN1, ATM, ATP13A2, ATP1A3, ATP2B3, ATP8A2, B9D1, BBS1, BBS12, BSCL2, BTD, C12orf65, C19orf12, CA8, CACNA1A, CACNB4, CAMTA1, CASK, CC2D2A, CCDC88C, CEP290, CEP41, CHMP1A, CLCN2, CLN5, CLN6, CLPP, COASY, COQ2, COQ8A,
[Show full text]